المؤلفون: Maldonado-Pérez, N., Tristán-Manzano, M., Justicia-Lirio, P., Martínez-Planes, E., Muñoz, P., Pavlovic, K., Cortijo-Gutiérrez, M., Blanco-Benítez, C., Castella, M., Juan, M., Wenes, M., Romero, P., Molina-Estévez, F.J., Marañón, C., Herrera, C., Benabdellah, K., Martin, F.

المصدر: Frontiers in immunology, vol. 13, pp. 1011858

مصطلحات موضوعية: Humans, Receptors, Chimeric Antigen/genetics, Immunotherapy, Adoptive/adverse effects, Adoptive/methods, T-Lymphocytes, Precursor Cell Lymphoblastic Leukemia-Lymphoma/therapy, Lymphoma, B-Cell/etiology, CAR-T cells, CRISPR/Cas9, TCRKO, large deletions, off-the-shelf, safety

وصف الملف: application/pdf

Relation: info:eu-repo/semantics/altIdentifier/pmid/36275777; info:eu-repo/semantics/altIdentifier/eissn/1664-3224; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_3B47882380989; https://serval.unil.ch/notice/serval:BIB_3B4788238098; https://serval.unil.ch/resource/serval:BIB_3B4788238098.P001/REF.pdf

الاتاحة: https://serval.unil.ch/notice/serval:BIB_3B4788238098
https://doi.org/10.3389/fimmu.2022.1011858
https://serval.unil.ch/resource/serval:BIB_3B4788238098.P001/REF.pdf
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_3B47882380989